New Congress to Be Sworn In: Taking Stock (1/2)

Jan. 2 (Bloomberg) -- On today's "Taking Stock," Carol Massar takes stock of the market close and the stories moving today's headlines. (Source: Bloomberg)

Gilead Science's Falls Most in Almost Three Months
55:53 - Gilead Sciences Inc. fell the most in almost three months after the company cut its product sales forecast for 2016 and reported lower-than-expected quarterly sales for its hepatitis C drugs. Bloomberg's Asthika Goonewardene reports on "Bloomberg Markets." (Source: Bloomberg)
  • Nigerian Central Bank Raises Its Key Interest Rate
  • AB Inbev Sweetens SABMiller Offer
  • Where's the Love for European Stocks?